Press Releases

Read our latest announcements

Filter by year:

2015-11-19
Modus Therapeutics strengthens its board

Jim Van heusden is CEO of Karolinska Development, having joined in March 15. He has more than 20 years’ experience in venture capital, and drug development.

View Press Release
2015-11-13
Modus Therapeutics to attend BIO-Europe 2015

Modus Therapeutics AB will be attending BIO-Europe 2015 in Munich, Germany.

View Press Release
2015-10-13
Modus Therapeutics and Ergomed Initiate Phase II Clinical Trial with Modus’ Sevuparin in Sickle-Cell Disease

Modus Therapeutics today announced that the first patient has been enrolled in the Phase II study with sevuparin in patients with SCD.

View Press Release
2015-09-01
Modus Therapeutics to present at Nordic Life Science Days 2015

Modus Therapeutics AB announces its Chief Executive Officer Christina Herder is to present at Nordic Life Science Days 2015 conference.

View Press Release
2015-08-02
New HQ in Stockholm for Modus Therapeutics

Modus Therapeutics AB, a Karolinska Development (STO:KDEV) portfolio company, is set to move headquarters in the coming month.

View Press Release
2015-03-20
Modus Therapeutics receives Orphan Drug Designation in the U.S. for sevuparin in Sickle-Cell Disease

Modus Therapeutics AB today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for sevuparin (DF02).

View Press Release
2015-02-19
Modus Therapeutics Announces Co-Development Agreement with Ergomed for Sickle-Cell Disease Treatment

Ergomed plc (LSE: ERGO or ‘Ergomed’) and Modus Therapeutics AB (‘Modus Therapeutics’) today announced that they have entered into a co-development agreement.

View Press Release
2015-01-19
Modus Therapeutics receives positive COMP opinion on Orphan Drug Designation in the EU for sevuparin in Sickle-Cell Disease

Modus Therapeutics AB today announced that it has received positive opinion from the Committee for Orphan Medicinal Products on orphan drug designation in the EU for sevuparin.

View Press Release